CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 90 filers reported holding CYTEK BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $87,238 | -66.8% | 15,804 | -48.6% | 0.00% | – |
Q2 2023 | $262,681 | -93.1% | 30,759 | -92.6% | 0.00% | -100.0% |
Q1 2023 | $3,822,047 | +239.9% | 415,892 | +277.6% | 0.00% | – |
Q4 2022 | $1,124,550 | +10.6% | 110,142 | +59.4% | 0.00% | – |
Q3 2022 | $1,017,000 | -64.2% | 69,100 | -73.9% | 0.00% | -100.0% |
Q2 2022 | $2,843,000 | +941.4% | 264,928 | +945.1% | 0.00% | – |
Q1 2022 | $273,000 | -81.9% | 25,349 | -72.6% | 0.00% | – |
Q4 2021 | $1,508,000 | +359.8% | 92,369 | +503.0% | 0.00% | – |
Q3 2021 | $328,000 | – | 15,318 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Miura Global Management | 2,117,500 | $45,336,000 | 7.03% |
RA Capital Management | 9,607,028 | $205,686,000 | 2.85% |
Octagon Capital Advisors LP | 500,000 | $10,705,000 | 2.64% |
HHLR ADVISORS, LTD. | 8,757,030 | $187,488,000 | 2.45% |
REILLY FINANCIAL ADVISORS, LLC | 79,979 | $10,643,000 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 328,080 | $7,024,000 | 0.58% |
Orbimed Advisors | 1,923,139 | $41,174,000 | 0.45% |
PURA VIDA INVESTMENTS, LLC | 444,368 | $9,514,000 | 0.29% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 441,518 | $9,453,000 | 0.11% |
FIL Ltd | 2,666,600 | $57,092,000 | 0.06% |